Navigation Links
Embracing debate on how cancers develop: Without the answer, effective therapies remain elusive
Date:1/16/2013

New Rochelle, NY, January 16, 2013Scientists invariably conduct debates in private about whether a body of scientific work or thought is worthy of presentation to the community. Behind closed doors scientists and editors tussle over when is the right time to publish their work. In a disruptive departure from this norm, Disruptive Science and Technology, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers, has launched a Debate section in which ideas and counterpoints can be debated in public. The Journal seeks not to sway opinions but rather to inform them. It is fitting that the first series of debates is focused on the root cause of cancer.

Most cancer researchers would likely agree that not understanding how cancer develops is a major obstacle in the ongoing "war on cancer." However, in some scientists' minds the mechanism that underlies tumor development is not settled science. Under the Somatic Mutation Theory, cancers arise as a consequence of changes to DNA, while the Tissue Organization Field Theory states that they result from disruptions in normal cell communication needed to correctly form tissues. The initial debate explores these two major theories of cancer development in Disruptive Science and Technology, and the articles are available free on the Journal website at http://www.liebertpub.com/dst.

Stuart Baker, ScD, National Cancer Institute (Bethesda, MD), initiates the debate with the article, "Paradoxes in Carcinogenesis Should Spur New Avenues of Research: An Historical Perspective." Dr. Baker describes "paradigm instability" between the two main explanations of how cancer develops the more the dominant theory is investigated without a conclusive resolution, the more proponents think they are getting closer to understanding and the more others think the evidence is pointing to an alternative theory. Dr. Baker discusses paradoxes experimental and observational results that are not fully explained by one theory but which make sense under the other. He proposes focusing more research on explaining these paradoxes.

Vincent Wilson, PhD, Louisiana State University (Baton Rouge, LA), emphasizes that cancer develops as a result of both genetic and environmental factors in "Carcinogenesis as the Sum of Its Parts." Regardless of the specific causative event, multiple changes are required for an individual cancer cell and a tumor to develop. He suggests either combining the two main proposals for the mechanism of carcinogenesis, or subdividing cancer into subgroups developing specific hypotheses to explain the cause of each type.

Eric Lagasse, PharmD, PhD, University of Pittsburgh School of Medicine (PA), argues in "Battling Cancer: In the End What Matters the Most?" that while the initial event resulting in cancer is not yet clear, pointing out yet another cancer formation theory (Cancer Stem Cell Theory), cancer treatment can be improved by tailoring therapy to target the genetic characteristics of a patient's most aggressive tumor cells and to continue to monitor and modify treatment as needed to overcome drug resistance.

"The mechanisms underlying cancer formation are complex and not completely understood, even after some victories in the 'war on cancer,'" says Editor-in-Chief Alan J. Russell, PhD, Highmark Distinguished Career Professor, Carnegie Mellon University, Pittsburgh, PA. "Drs. Baker, Wilson, and Lagasse present different points of view as to the most likely explanations for carcinogenesis. A deeper understanding of cancer mechanisms is important for designing therapeutics and formulating new research questions."


'/>"/>

Contact: Sophie Mohin
smophin@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related medicine news :

1. U.S. Doctors Embracing Electronic Health Records: Survey
2. Screening Debate Typifies Prostate Cancer Uncertainties
3. Vaccine and autism debate masks real problem
4. Latest coffee and health research to be debated at the World Congress on Prevention of Diabetes
5. Preventive screening for sudden cardiac death in young athletes debated
6. Evidence on abortion figures overestimated in Mexico fuels scientific debate in medical journal
7. Debate Heats Up Over Screening Athletes for Sickle Cell Trait
8. Protein recognition and disorder: A debate
9. Cannabis use and the increased risk of psychosis: The debate continues
10. HPV-Related Head, Neck Cancers on the Rise
11. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Embracing debate on how cancers develop: Without the answer, effective therapies remain elusive
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: